Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The efficAcy and Safety of aPixaban In REal-world Practice in Korean Frail Patients With Atrial Fibrillation: a Prospective Multicenter Non-interventional, Observational Study: ASPIRE Study

NCT05773222 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05773222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05773222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The efficAcy and Safety of aPixaban In REal-world Practice in Korean Frail Patients With Atrial Fibrillation: a Prospective Multicenter Non-interventional, Observational Study: ASPIRE Study
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
August 12, 2019
Completion date
May 26, 2023
Enrollment
2,002 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation